MOR106
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MOR106, covering 2021-01-05 to 2021-01-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]